Medicine
M. Doi, N. Hirata, Toshiyasu Suzuki, H. Morisaki, H. Morimatsu, A. Sakamoto
2020.4.17Journal of Anesthesia
tlooto Summary
Both induction regimens were equally efficacious and safe in surgical patients ASA Class III, and a significantly shorter time to LoC was observed with the higher remimazolam dosage.
Abstract
Abstract is not available.
Citation format
DOI, M., et al. Safety and efficacy of remimazolam in induction and maintenance of general anesthesia in high-risk surgical patients (ASA class III): Results of a multicenter, randomized, double-blind, parallel-group comparative trial. Journal of Anesthesia, 2020: 1–11.